Alan S. Braverman - Concepedia

Author

Alan S. Braverman

Also Known As

A Braverman, A S Braverman, A. BRAVERMAN, A. Braverman, A. S. Braverman, A.S. Braverman, ALAN S. BRAVERMAN, Alan Braverman, Alan Braverman*, Alan S Braverman

138

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Temple University Shriners Hospitals for Children - Philadelphia Massachusetts General Hospital Fox Chase Cancer Center Allegheny College

About

Alan S. Braverman is an author at Temple University specializing in medicine, urology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	459
2	Natural Sciences	1	1	51
3	Social Sciences	1	1	105
4	Allergy	1	1	48
5	Anatomy	1	1	25

Alan S. Braverman

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
M<sub>2</sub>muscarinic receptor contributes to contraction of the denervated rat urinary bladder Alan S. Braverman, G R Luthin, Michael R. Ruggieri American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	1998	122
The M<sub>2</sub> muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction Michel A. Pontari, Alan S. Braverman, Michael R. Ruggieri American Journal of Physiology-Regulatory, Integrative and Comparative Physiology Pain MedicineNeurotransmitterPharmacotherapyNeurotransmissionExperimental Pharmacology	2004	105
Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M<sub>3</sub>toward M<sub>2</sub> Alan S. Braverman, Michael R. Ruggieri American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	2003	97
M2 receptors in genito-urinary smooth muscle pathology Alan S. Braverman, Jeffrey J. Legos, William J. Young, Life Sciences UrologyMolecular PhysiologySkeletal MuscleG Protein-coupled ReceptorPhysiology	1999	82
M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. I. Normal Rat Bladder Alan S. Braverman, Amit Tibb, Michael R. Ruggieri Journal of Pharmacology and Experimental Therapeutics	2006	68
Analysis of the Plasma Proteome in COPD: Novel Low Abundance Proteins Reflect the Severity of Lung Remodeling Salim Merali, Carlos A. Barrero, Russell P. Bowler, COPD Journal of Chronic Obstructive Pulmonary Disease AsthmaInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationImmunology	2013	56
Immunodepletion Plasma Proteomics by TripleTOF 5600 and Orbitrap Elite/LTQ-Orbitrap Velos/Q Exactive Mass Spectrometers Kelly A. Jones, Phillip D. Kim, Bhavinkumar B. Patel, Journal of Proteome Research Mass Spectrometry ParametersImmunologyMolecular BiologyProteomic TechnologyBioanalysis	2013	51
Prejunctional M<sub>1</sub>facilitory and M<sub>2</sub>inhibitory muscarinic receptors mediate rat bladder contractility Alan S. Braverman, Ira J. Kohn, G R Luthin, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	1998	51
M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. II. Denervated Rat Bladder Alan S. Braverman, Leo Doumanian, Michael R. Ruggieri Journal of Pharmacology and Experimental Therapeutics	2006	51
Assessment of Two Immunodepletion Methods: Off-Target Effects and Variations in Immunodepletion Efficiency May Confound Plasma Proteomics Bhavinkumar B. Patel, Carlos A. Barrero, Alan S. Braverman, Journal of Proteome Research Laboratory ImmunologyImmunologyPathologyImmunotherapyProtein Purification	2012	48

Page 1